Tirzepatide and Tesamorelin Stack with IGF-1 LR3
Explore how tesamorelin and IGF-1 LR3 may mitigate muscle loss during tirzepatide-assisted weight loss, with insights on oxytocin, MOTS-c, and kisspept
Read articleResearch & Insights
From the lab.
Science-backed reads on peptide research, protocols, and compound data.
More articles
Tesamorelin + Kisspeptin Stack for Tirzepatide Libido Loss
The FDA panel vote on tirzepatide access has reshaped conversations around GLP-1 receptor agonists and their unintend...
Tesamorelin and IGF-1 LR3 Stack for Lean Mass Preservation During Tirzepatide-Assisted Weight Loss: Timing and Dosing After the FDA Panel Vote on Peptide Access
Explore how tesamorelin and IGF-1 LR3 can preserve lean mass during tirzepatide weight loss, with dosing, timing, and...
Tirzepatide and Oxytocin Stack for Menstrual Side Effects
Tirzepatide can disrupt menstrual cycles in some women. Research explores oxytocin, tesamorelin, MOTS-c, and kisspept...
Tirzepatide + MOTS-c Stack for Metabolic Flexibility
Explore key research on Tirzepatide and MOTS-c for metabolic flexibility, targeting fat loss while mitigating fatigue...